These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 698048

  • 1. Effect of phenobarbital on plasma levels of cyclophosphamide and its metabolites in the mouse.
    Alberts DS, Peng YM, Chen HS, Struck RF.
    Br J Cancer; 1978 Aug; 38(2):316-24. PubMed ID: 698048
    [Abstract] [Full Text] [Related]

  • 2. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
    Struck RF, Alberts DS.
    Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide.
    Plowchalk DR, Mattison DR.
    Toxicol Appl Pharmacol; 1991 Mar 01; 107(3):472-81. PubMed ID: 2000634
    [Abstract] [Full Text] [Related]

  • 5. Isophosphoramide mustard, a metabolite of ifosfamide with activity against murine tumours comparable to cyclophosphamide.
    Struck RF, Dykes DJ, Corbett TH, Suling WJ, Trader MW.
    Br J Cancer; 1983 Jan 01; 47(1):15-26. PubMed ID: 6821629
    [Abstract] [Full Text] [Related]

  • 6. Effect of phenobarbital on cyclophosphamide cytotoxic activity and pharmacokinetics in mice.
    Donelli MG, Vecchi A, Bossi A, Colombo T, Sironi M, Pantarotto C, Garattini S, Spreafico F.
    Tumori; 1977 Jan 01; 63(2):137-46. PubMed ID: 898284
    [Abstract] [Full Text] [Related]

  • 7. Plasma concentrations of 4-hydroxycyclophosphamide and phosphoramide mustard in patients repeatedly given high doses of cyclophosphamide in preparation for bone marrow transplantation.
    Sladek NE, Doeden D, Powers JF, Krivit W.
    Cancer Treat Rep; 1984 Oct 01; 68(10):1247-54. PubMed ID: 6395951
    [Abstract] [Full Text] [Related]

  • 8. Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat.
    Genka S, Deutsch J, Stahle PL, Shetty UH, John V, Robinson C, Rapoport SI, Greig NH.
    Cancer Chemother Pharmacol; 1990 Oct 01; 27(1):1-7. PubMed ID: 2245487
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
    Spielmann H, Jacob-Müller U.
    Teratology; 1981 Feb 01; 23(1):7-13. PubMed ID: 7245091
    [Abstract] [Full Text] [Related]

  • 11. Isolation and mass spectral identification of blood metabolites of cyclophosphamide: evidence for phosphoramide mustard as the biologically active metabolite.
    Struck RF, Kirk MC, Witt MH, Laster WR.
    Biomed Mass Spectrom; 1975 Feb 01; 2(1):46-52. PubMed ID: 1131393
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats.
    Powers JF, Sladek NE.
    Cancer Res; 1983 Mar 01; 43(3):1101-6. PubMed ID: 6825082
    [No Abstract] [Full Text] [Related]

  • 13. Analysis of phosphoramide mustard by reversed-phase ion pair high pressure liquid chromatography.
    Hardy RW, Moore MJ, Erlichman C, Soldin SJ.
    Ther Drug Monit; 1987 Jun 01; 9(2):221-6. PubMed ID: 3617163
    [Abstract] [Full Text] [Related]

  • 14. Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial.
    Struck RF, Alberts DS, Horne K, Phillips JG, Peng YM, Roe DJ.
    Cancer Res; 1987 May 15; 47(10):2723-6. PubMed ID: 3552204
    [Abstract] [Full Text] [Related]

  • 15. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF.
    Teratology; 1989 Jul 15; 40(1):11-20. PubMed ID: 2763206
    [Abstract] [Full Text] [Related]

  • 16. Cimetidine enhancement of cyclophosphamide antitumour activity.
    Dorr RT, Alberts DS.
    Br J Cancer; 1982 Jan 15; 45(1):35-43. PubMed ID: 7059463
    [Abstract] [Full Text] [Related]

  • 17. The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
    Momerency G, Van Cauwenberghe K, Slee PH, Van Oosterom AT, De Bruijn EA.
    Biol Mass Spectrom; 1994 Mar 15; 23(3):149-58. PubMed ID: 8148406
    [Abstract] [Full Text] [Related]

  • 18. Cyclophosphamide metabolism in children.
    Yule SM, Boddy AV, Cole M, Price L, Wyllie R, Tasso MJ, Pearson AD, Idle JR.
    Cancer Res; 1995 Feb 15; 55(4):803-9. PubMed ID: 7850793
    [Abstract] [Full Text] [Related]

  • 19. Rapid quantitation of cyclophosphamide metabolites in plasma by liquid chromatography-mass spectrometry.
    Kalhorn TF, Howald WN, Cole S, Phillips B, Wang J, Slattery JT, McCune JS.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May 01; 835(1-2):105-13. PubMed ID: 16581318
    [Abstract] [Full Text] [Related]

  • 20. Characterizing the ovotoxicity of cyclophosphamide metabolites on cultured mouse ovaries.
    Desmeules P, Devine PJ.
    Toxicol Sci; 2006 Apr 01; 90(2):500-9. PubMed ID: 16381661
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.